Rep. Allen Pricing Focus Shifts From FSS To Medicare Rx Plans
Private-insurance based Medicare proposals do not offer enough leverage on price, Rep. Allen (D-Maine) told a May 3 briefing on health care sponsored by the Council for Affordable Health Insurance in Washington, D.C.
You may also be interested in...
House Democrats are considering whether legislation to create a PBM-administered Medicare prescription drug benefit should allow HHS to issue rules ensuring that the Medicare program receives drugs at the same prices as other large group purchasers.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011